Search results
Results from the WOW.Com Content Network
May 1, 2024 at 1:29 PM. By Bhanvi Satija and Patrick Wingrove. (Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates ...
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. The company's dividend is $0.42 per share quarterly, or $1.68 annually. It's ...
Pfizer ( PFE) beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday. The company reported $14.9 billion in revenue, down 19% compared to last year. That ...
ViiV Healthcare. ViiV Healthcare ( / ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London. The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies ...
Pfizer Inc. ( / ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Here are three reasons investors should consider snapping up Pfizer as a long-term investment with market-beating potential. 1. This 6% dividend yield is no trap. Pfizer has long been a dividend ...
Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [12] [13] Had this transaction been completed, this would have been the largest within this industry. 2. 2014. Pfizer.